(Q47720040)
Statements
Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial (English)
Amisha Singapuri
Michelle Bourne
Vijay Mistry
Ruth Hartley
Sherif Gonem
Marie F M Laurencin
Gerald Bacher